Organisations move against chronic ailments in Nigeria.
Society for Family Health (SFH) and Novartis Social Business have signed an agreement to implement Novartis Access in the country.
Through the partnership, SFH would be distributing Novartis Access medicines to treat chronic diseases among the most vulnerable populations in health facilities across Nigeria.
Managing director of SFH, Sir Bright Ekweremadu, noted: “Nigeria is increasingly affected by the burden of non-communicable diseases (NCDs) as lifestyles and habits become more sedentary. We have been working for more than 30 years to help Nigerians, particularly the poor and most vulnerable, to live healthier lives by improving access to essential health services.
“This collaboration with Novartis Social Business is part of the solutions to the challenges of the poor who are most at risk of NCDs.”
The collaboration also involves capacity-building and community awareness.
The Novartis Access portfolio includes high-quality medicines targeting four key NCDs namely cardiovascular, Type 2 diabetes, respiratory illnesses, and breast cancer.
According to the World Health Organisation (WHO), Nigeria is burdened by the diseases, and there is the probability of people dying due to one of the four between the ages of 30 and 70 was 20 percent nationwide